Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind over menopause: guided imagery eases sleep woes

NCT ID NCT07176611

Symptom relief Sponsor: Menekşe Nazlı AKER Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether guided imagery—a relaxation technique using calming mental images—can improve quality of life and reduce insomnia in perimenopausal women aged 45 to 59. Sixty-eight women were randomly assigned to either a guided imagery group or a control group. Researchers measured changes in menopausal symptoms and sleep quality using standard questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

68 people

The number who actually took part.

Started

Sep 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being between 45-59 years of age * Being in the perimenopausal period according to the Stages of Reproductive Aging Workshop (STRAW) criteria (stage +1 or +2) * Early menopausal transition (STRAW -2): menstrual cycle length varies by 7 days or more * Late menopausal transition (STRAW -1): amenorrhea lasting 60 days or longer * Having entered natural menopause in postmenopausal women * Scoring above 10 on the Women's Health Initiative Insomnia Rating Scale * Owning a smartphone * Ability to understand and speak Turkish * No hearing impairment * Volunteering to participate in the study Exclusion Criteria: * Having received or currently receiving hormone replacement therapy * Alcohol use * Practicing another mind-body intervention * Having a diagnosed disease that may cause sleep disorders and receiving medical treatment * Having a diagnosed disease that may significantly affect quality of life and receiving medical treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perimenopausal women are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perimenopausal women

Contacts and locations

Locations

  • Akdağmadeni Public Education Center

    Yozgat, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.